Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Clinical and Pharmacokinetic Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

NCT00374660 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00374660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00374660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Clinical and Pharmacokinetic Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
Lead sponsor
Eisai Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2003
Completion date
April 30, 2007
Enrollment
63 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer